These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 22300486)

  • 1. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
    Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
    Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.
    Rasquin SM; Lodder J; Visser PJ; Lousberg R; Verhey FR
    Dement Geriatr Cogn Disord; 2005; 19(2-3):113-9. PubMed ID: 15591801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.
    Espinosa A; Alegret M; Valero S; Vinyes-Junqué G; Hernández I; Mauleón A; Rosende-Roca M; Ruiz A; López O; Tárraga L; Boada M
    J Alzheimers Dis; 2013; 34(3):769-80. PubMed ID: 23271318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study.
    Pusswald G; Moser D; Gleiss A; Janzek-Hawlat S; Auff E; Dal-Bianco P; Lehrner J
    Alzheimers Dement; 2013 Jul; 9(4):366-76. PubMed ID: 23164551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies.
    Oltra-Cucarella J; Ferrer-Cascales R; Alegret M; Gasparini R; Díaz-Ortiz LM; Ríos R; Martínez-Nogueras ÁL; Onandia I; Pérez-Vicente JA; Cabello-Rodríguez L; Sánchez-SanSegundo M
    Psychol Aging; 2018 Nov; 33(7):1007-1021. PubMed ID: 30284855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of mild cognitive impairment to dementia due to AD in clinical settings.
    Tifratene K; Robert P; Metelkina A; Pradier C; Dartigues JF
    Neurology; 2015 Jul; 85(4):331-8. PubMed ID: 26136516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Bradfield NI; Ellis KA; Savage G; Maruff P; Burnham S; Darby D; Lautenschlager NT; Martins RN; Masters CL; Rainey-Smith SR; Robertson J; Rowe C; Woodward M; Ames D
    Alzheimer Dis Assoc Disord; 2018; 32(3):190-196. PubMed ID: 29561277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion pattern and predictive factor of mild cognitive impairment in elderly Koreans.
    Shim SM; Song J; Kim JH; Jeon JP
    Arch Gerontol Geriatr; 2016; 64():146-50. PubMed ID: 26896864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease?
    Meyer JS; Xu G; Thornby J; Chowdhury MH; Quach M
    Stroke; 2002 Aug; 33(8):1981-5. PubMed ID: 12154249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study.
    Roed L; Grave G; Lindahl T; Rian E; Horndalsveen PO; Lannfelt L; Nilsson C; Swenson F; Lönneborg A; Sharma P; Sjögren M
    J Alzheimers Dis; 2013; 35(3):611-21. PubMed ID: 23478308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild cognitive impairment: risk of dementia according to subtypes.
    Serrano CM; Dillon C; Leis A; Taragano FE; Allegri RF
    Actas Esp Psiquiatr; 2013; 41(6):330-9. PubMed ID: 24203505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of mild cognitive impairment of Alzheimer's disease by Simoa p-tau181 measurements with matching plasma and CSF.
    Wu L; Arvai S; Wang SJ; Liu AJ; Xu B
    Front Mol Neurosci; 2023; 16():1288930. PubMed ID: 38260807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer's Disease.
    Liampas I; Folia V; Morfakidou R; Siokas V; Yannakoulia M; Sakka P; Scarmeas N; Hadjigeorgiou G; Dardiotis E; Kosmidis MH
    Arch Clin Neuropsychol; 2023 May; 38(4):525-536. PubMed ID: 36244060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.